Hold Sun Pharma; target of Rs 525: Sharekhan

Sharekhan recommended Hold rating on Sun Pharma with a target price of Rs 525 in its research report dated December 04, 2018.

Broker Research

December 05, 2018 / 15:40 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Sharekhan's research report on Sun Pharma

Sun Pharma continues to remain surrounded by issues, the recent one being a whistle blower case filed with SEBI. Related party structure raises concerns among investors.

Outlook

We downgrade our recommendation to Hold with downward revised PT of Rs. 525.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Broker Research

first published: Dec 5, 2018 03:40 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347